Searched for
DIOVAN
Dr Reddy's launches drug to treat high blood pressure, heart failure in US marketCiting IQVIA Health data, the company said the Diovan brand and generic market had US sales of approximately USD 150 million for the most r...- Jubilant Life gets ANDA approval for Valsartan tab; stock surges 7%The generic version of Novartis’ Diovan is used for treatment of hyper-tension. The current annualized US market size for the drugs is $2 b...
- Ranbaxy stock up 50% post deal with Sun Pharma; co grabs 13% market share after Diovan’s launchUnder the terms of the acquisition, for every five shares held in Ranbaxy, shareholders are going to receive four of Sun Pharma.
- Ranbaxy shares jump on approval of generic drug DiovanRanbaxy should be able to generate $190 million of sales and an after-tax profit of $100 million during 180 days, said a research analyst.
- Ranbaxy gets FDA nod to sell generic Diovan tablets in USRanbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed to sell generic Valsartan tablets.
- Ranbaxy Laboratories rallies over 8% on USFDA nod for Diovan's generic versionThe pharma major also enjoys a 180 days exclusive marketing opportunity, said two industry executives with direct knowledge of the matter t...
- Ranbaxy to launch generic Diovan in USRanbaxy’s CEO had said in a conference call that the company is confident that retains the exclusivity opportunities in US and would moneti...
- Ranbaxy's hunt for FDA-okayed plants in India pushes stock higherRanbaxy is looking at FDI-okayed plants in an attempt to reduce risks arising out of issues with its Mohali plant, said two persons familia...
- USFDA import ban on Ranbaxy's Mohali plant to hit future launchesWith the problems with the USFDA showing no signs of abating, investors are unlikely to repose confidence in the stock any time soon.
- Ranbaxy Laboratories ends 30% lower on USFDA import alert for Mohali plantRanbaxy Laboratories plunged 35% on Monday on reports that USFDA has issued an import alert for drugs manufactured at its plant in Mohali.
- Ranbaxy Labs rallies 60% since August, loses 35% in a day thanks to FDA: Time to book profits?Analysts at top brokerage firms have turned cautious on Ranbaxy after reports that the FDA has issued an import alert on the Mohali unit.
- CLSA lowers Ranbaxy's target price as it delays drug launchCLSA has maintained its outperform rating on Ranbaxy but has revised its target price downward as it has delayed its launch of generic Diov...
- Ranbaxy’s drug Diovan's delay trims Novartis’ lossesRanbaxy, which holds 180-day exclusivity for the generic version of the drug, was originally schedule to launch the drug in the US market i...
- Lupin stock vaults to 52-week high on generic launch of Novartis' DiovanThe stock has gained 25% in the last one year – and has been one of the best performing stocks among the frontline pharma companies.
- Lupin gets USFDA nod for generic hypertension drugLupin today said it has received US health regulator's approval to market generic version of Novartis Pharmaceuticals Corp's Diovan HCT Tab...
- American consumers approach court to consider recall of Ranbaxy's generic drug lipitorLast November, Ranbaxy had effected a limited recall of 41 lots of the drug from US pharmacies as it feared some of its drugs may be contai...
- Mylan sues USFDA for allowing Ranbaxy to sell Diovan's generic versionMylan has sued USFDA for not allowing it to market a generic version of medicine Diovan, saying that Ranbaxy has lost its exclusivity for t...
- Ranbaxy misses out on first-day launch of hypertension drug's generic versionThe company is yet to get the US food and Drug Administration's approval for the generic version of the drug, valsartan.
- Ranbaxy Laboratories shifts production of Lipitor generic to MohaliRanbaxy Laboratories has started shifting production of its generic version of the world's bestselling drug Lipitor from the US to its new ...
- Novartis says Q1 profit up 49 pcDrug maker Novartis AG said on Tuesday that strong sales particularly of swine flu vaccine helped increase net profit by 49 per cent to $2....
Load More
